Information Provided By: 
Fly News Breaks for October 7, 2015
EXAS
Oct 7, 2015 | 07:18 EDT
Canaccord lowered its price target on Exact Sciences to $13 from $26 following the classification of Cologuard as an "alternative test". The firm notes the public comment period lasts until November 2 and expects a broad pool of stakeholders to state objections and apply pressure to convince the Task Force to include Cologuard as an "A" test in its final decision. Canaccord maintained its Buy rating on Exact Sciences shares.
News For EXAS From the Last 2 Days
There are no results for your query EXAS
